WOODCLIFF LAKE, N.J., Oct. 24, 2014 /PRNewswire/ -- Eisai Inc., a leader in the epilepsy community, announces the launch of the "Search for the Next Medikidz Star," a consumer contest to identify a child living with...
Epilepsy is not a priority for local healthcare decision makers in England according to a new report, published October 22, 2014 by national charity Epilepsy Action.
Epidiolex® receives orphan designation from European Medicines Agency for the treatment of Dravet syndrome
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, has announced that...
Long-term safety and efficacy of once-daily Zonegran® (zonisamide) monotherapy demonstrated in extension of pivotal study
Zonegran® (zonisamide) continues to be well-tolerated and efficacious when used as long-term montherapy for the treatment of partial onset seizures in adults with newly diagnosed epilepsy, as...
The name of some clinics for people with epilepsy is changed following a complaint it was offensive.
The Department of Health said medicine shortages are a global issue but it works with health professionals to avoid and manage them when they arise.